Results 1 to 10 of about 1,174,175 (255)

Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study

International Journal of Endocrinology, 2022
Introduction. Papillary thyroid cancer (PTC) is one of the most prevalent endocrine malignancies that has increased in recent decades around the world.
Liu Yihao, Li Shuo, Xi Pu, Wang Zipeng, Sun Hanlin, Chang Qungang, Wang Yongfei, Yin Detao   +7 more
doaj   +1 more source

Practice patterns and outcomes in the management of Thai patients with Graves’ disease

Thyroid Research, 2021
Background The treatment of hyperthyroid Graves’ disease (GD) varies considerably among geographic areas. In this study, we aimed to evaluate practice patterns and treatment outcomes in Thai patients with hyperthyroid GD.
Yotsapon Thewjitcharoen, Krittadhee Karndumri, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanathayanoroj, Nampetch Lekpittaya, Worawit Kittipoom, Tawee Anuntakulnatee, Somboon Vongterapak, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam   +13 more
doaj   +1 more source

2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management

European Thyroid Journal, 2023
With the widespread use of sensitive imaging techniques, which include neck visualization, a conspicuous number of thyroid nodules emerge and demand attention. Most lesions are benign, asymptomatic, and do not warrant treatment.
C. Durante, L. Hegedüs, A. Czarniecka, R. Paschke, G. Russ, F. Schmitt, Paula Soares, T. Solymosi, E. Papini   +8 more
semanticscholar   +1 more source

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

International Journal of Endocrinology, 2022
Background. The BRAF V600E mutation is an important genetic event in papillary thyroid cancer (PTC). This study aimed to provide additional information regarding the association of the BRAF V600E mutation with PTC prognosis. Methods.
Ziheng Ye, Xiaotian Xia, Peipei Xu, Wenfei Liu, Shoufei Wang, Youben Fan, Minggao Guo   +6 more
doaj   +1 more source

Transcription Factor E2F1 Exacerbates Papillary Thyroid Carcinoma Cell Growth and Invasion via Upregulation of LINC00152

Analytical Cellular Pathology, 2022
Background. Papillary thyroid carcinoma (PTC) is the most common thyroid neoplasm, whereas transcription factor E2F1 has been previously implicated in PTC progression.
Junjie Yang, Yong Ying, Xiangtai Zeng, Jiafeng Liu, Yang Xie, Zefu Deng, Zhiqiang Hu, Zanbin Li   +7 more
doaj   +1 more source

Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand

BMC Endocrine Disorders, 2020
Background After years of decline, the rate of amputations was reported to increase by 50% in the U.S. population between 2009 and 2015. Few studies have examined the most recent trends in hospitalized diabetic foot ulcer (DFU) in Asian patients.
Yotsapon Thewjitcharoen, Jeeraphan Sripatpong, Sirinate Krittiyawong, Sriurai Porramatikul, Taweesak Srikummoon, Somkiet Mahaudomporn, Siriwan Butadej, Soontaree Nakasatien, Thep Himathongkam   +8 more
doaj   +1 more source

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most ...
R. Haddad, Lindsay A. Bischoff, D. Ball, V. Bernet, E. Blomain, N. Busaidy, Michael Campbell, P. Dickson, Q. Duh, H. Ehya, W. Goldner, Theresa W. Guo, Megan R. Haymart, Shelby Holt, J. Hunt, A. Iagaru, F. Kandeel, D. Lamonica, S. Mandel, S. Markovina, B. McIver, C. Raeburn, R. Rezaee, J. Ridge, Mara Y. Roth, R. Scheri, J. Shah, J. Sipos, R. Sippel, C. Sturgeon, T. Wang, L. Wirth, R. Wong, Michael Yeh, Carly J. Cassara, S. Darlow   +35 more
semanticscholar   +1 more source

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

Journal of Immunology Research, 2022
Yin-Yang 1 (YY1) has a crucial function in the development of several malignancies, according to recent research. However, nothing is known about its aberrant expression and prognostic significance in human pan-cancer.
Xinghao Fu, Feihong Ji, Qi He, Xinguang Qiu   +3 more
doaj   +1 more source

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.

Diabetes Care, 2022
OBJECTIVE To determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) is associated with increased risk of thyroid cancer. RESEARCH DESIGN AND METHODS A nested case-control analysis was performed with use of the French national ...
J. Bezin, A. Gouverneur, M. Pénichon, C. Mathieu, R. Garrel, D. Hillaire-Buys, A. Pariente, J. Faillie   +7 more
semanticscholar   +1 more source

General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules: An American Thyroid Association Statement

Thyroid, 2023
Background: The primary goal of this interdisciplinary consensus statement is to provide a framework for the safe adoption and implementation of ablation technologies for benign thyroid nodules. Summary: This consensus statement is organized around three
C. Sinclair, J. Baek, Kathleen E. Hands, S. Hodak, T. Huber, Iram Hussain, B. Lang, Julia E. Noel, Maria Papaleontiou, Kepal N. Patel, G. Russ, J. Russell, S. Spiezia, Jennifer H. Kuo   +13 more
semanticscholar   +1 more source